Navigation Links
Health Robotics Announces December Launch of the i.v.SOFT(TM) Workflow Engine at ASHP in Las Vegas
Date:11/4/2009

BOZEN, Italy, November 4 /PRNewswire/ -- Health Robotics today announced the worldwide presentation and launch of its new i.v.SOFT Workflow Engine at the American Society of Health-System Pharmacists' Mid-Year Meeting December 6-10 in Las Vegas. With the availability of the i.v.SOFT Workflow Engine, Health Robotics becomes the first and only company in the world to provide a total automation solution to fill the void of automated process control and patient safety in the I.V. Room.

i.v.SOFT's Workflow Engine represents a an additional revolutionary step by Health Robotics in completing its vision to fully automate IV Admixtures by providing state-of-the-art software automation tools to address the IV preparation of patient doses that cannot be physically handled by robotics technology due to a variety of reasons, such as hospital choices of ampoules, non-standard IV Bags, diverse Elastomeric infusion devices, etc.

The primary challenges in today's IV Admixture operations are serious medication errors such as drug exchange and accuracy mistakes, high costs, life-critical turn-around time, intravenous drugs waste, regulatory issues, and difficulty in maintaining adequately trained clinical staff. While market-leading robots CytoCare(TM) and i.v.STATION(TM) automatically and aseptically compound the majority of hazardous and non-hazardous IV doses, hospitals have demanded complementary automation solutions for the 20-30% of IV doses (depending on local market requirements) that need to be routed to manual compounding on BSCs (biological safety cabinets). i.v.SOFT Workflow Engine offers worldwide hospital pharmacies the ability to have their pharmacy technicians work more efficiently while at the same time reducing costs due to IV Admixtures that are typically lost or re-made.

"Building the i.v.SOFT Workflow Engine upon the product specifications, customer experience, software logic, and industrial component i
'/>"/>

SOURCE Health Robotics
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. ViroPharma to Present at Three November Healthcare Conferences
2. NOVAVAX to Present at Oppenheimer 20th Annual Healthcare Conference
3. Pragmedic Implements World-Class Healthcare Solution for Emaar Healthcare
4. PDL BioPharma to Present at Oppenheimer & Co. 20th Annual Healthcare Conference on November 4, 2009
5. Diabetics: 3tailer Partners with MyGlucoHealth on World's 1st Blood Glucose Meter with Wireless Bluetooth for Diabetes
6. Medication Adherence Technology Combines with Patient Outreach Program to Yield Healthier Populations and Reduce Healthcare Costs
7. Collaboration of Indianas Health Information Exchanges, State Organizations Submits Application for Health Information Technology Stimulus Funding
8. avVaa World Health Care Products Inc. Announces Access via Social Media Websites
9. Recently Approved Onglyza Is Covered by 44 Percent of Commercial Health Plans But Less Than One Percent of Medicare Plans for The Treatment of Type 2 Diabetes
10. Health Robotics Announces First Five i.v.STATION(TM) Robot Shipments and Receipt of 3L/3T Innovation Award
11. Frost & Sullivans 2009 Excellence in Healthcare Awards Banquet Honours Industrys Top Performers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...Nov. 20 Cell Therapeutic...ay that the Ninth Circuit Court of Appeals reverse...hould be allowed to pursue all of its claims again...strict Court for trial. CTI filed a complaint aga...bursement consultant for CTI,s product TRISENOX, i...
(Date:11/19/2009)...v. 19 Danish Prince Joachim inaugu...ol plant in Kalundborg, Denmark, on Wednesday, Nov... and largest 2nd generation ethanol demonstration ...used in the plant,s innovative process for convert..., was the first to market with commercial enzymes ...
(Date:11/19/2009).... 19 NeoStem, Inc. (NYSE...e following letter to its shareholders, discussing...f China Biopharmaceuticals Holdings, Inc. (CHBP), ...the People,s Republic of China. The merger gives N...harmaceutical Co. Ltd., CHBP,s primary operating s...
(Date:11/19/2009).... 19 /PRNewswire/ - Aegera Therapeutics Inc. annou...ndomized Phase 2B study of AEG35156, a targeted an...ultiple oncology indications. ,, The study, ent...he X-Linked Inhibitor of Apoptosis (XIAP) Antisens...arabine and Idarubicin in AML Following Failure of...
Breaking Biology Technology:Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2
...vember 10 Azur Pharma Limited ("Azur") today,anno...elop and,commercialise once-daily formulations of ...SE: ELN ) proprietary drug delivery technologies, ...ne is currently marketed in immediate release pres...ntegrating tablet brand,FazaClo(r). Clozapine is i...
...hina, Nov. 10 /Xinhua-PRNewswire-FirstCall/ -- She...TI) ("Shengtai" or "the,Company"), a leading manuf...ical grade glucose products in China, today announ...hree months ended September 30, 2008,after the clo...008.,Management will conduct a conference call on ...
...tion to be Webcast -, MONTVALE, N.J. ,Nov. 10 Sy...today that Noah Berkowitz, M.D.,Ph.D., President a...t at,the upcoming 10th Annual Investor Forum on Tu... event will be held November 10th - 12th at the Ne...itz will discuss the company,s planned commerciali...
Other Biology Technology:Azur Pharma and Elan Corporation (NYSE: ELN) Sign Agreement to Develop a Once-Daily Clozapine 2Shengtai Pharmaceutical Schedules 2009 First Quarter Financial Results and Conference Call 2Shengtai Pharmaceutical Schedules 2009 First Quarter Financial Results and Conference Call 3Synvista Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference 2
(Date:11/19/2009)...brain chemical with an unwieldy name: 4-hydroxybut...used as a date-rape drug. , Now, a team of Ohio...s by which 4-HB is metabolized by the body. "This ... Gibson, professor and chair of biological science...r of the research team. "It may provide new clues...
(Date:11/19/2009)...which cultivate fungus for food, have many remarka... list: the ant farmers, like their human counterpa...eir gardens grow. The finding, reported this week ...eviously unknown symbiosis between ants and bacter...have come to dominate the American tropics and sub...
(Date:11/19/2009)...in many countries of the world. It is widely used ... materials. It also is considered an exemplar plan...olution, and genome architecture. The authors of t...sed the first description of the B73 maize genome ...genetics and plant biology. The ten papers conside...
Breaking Biology News(10 mins):Researchers begin to decipher metabolism of sexual assault drug 2Like humans, ants use bacteria to make their gardens grow 2PLoS Genetics 2009 maize genome collection 2PLoS Genetics 2009 maize genome collection 3PLoS Genetics 2009 maize genome collection 4Instrumentation Laboratory Receives 510 28k 29 Clearance From FDA for HemosIL 28R 29 Liquid Heparin Assay 48866 1Instrumentation Laboratory Receives 510 28k 29 Clearance From FDA for HemosIL 28R 29 Liquid Heparin Assay 48866 2Instrumentation Laboratory Receives 510 28k 29 Clearance From FDA for HemosIL 28R 29 Liquid Heparin Assay 48866 3Video 3A Varicose Veins Much More Than a Cosmetic Issue Can Prove a Health Risk 12622 1Video 3A Varicose Veins Much More Than a Cosmetic Issue Can Prove a Health Risk 12622 2Video 3A Varicose Veins Much More Than a Cosmetic Issue Can Prove a Health Risk 12622 3Video 3A Varicose Veins Much More Than a Cosmetic Issue Can Prove a Health Risk 12622 4Oncothyreon appoints Scott Peterson as Vice President of Research and Development 12620 1Oncothyreon appoints Scott Peterson as Vice President of Research and Development 12620 2Oncothyreon appoints Scott Peterson as Vice President of Research and Development 12620 3
...xperimental Biology are pleased to announce that ...is the winner of this year,s JEB Outstanding Paper...r in The Journal of Experimental Biology at htt...ises the contribution of an outstanding young scie...was the first author on the paper ,Carbohydrate re...
...ptor-2 (SRC-2) a master regulator gene called a c...ls plummet. If they go another day without food, t... (low blood sugar) was unexpected, said Dr. Bert W...y at Baylor College of Medicine and senior author ...rent issue of the journal Science . Normal mice l...
...wn to Thanksgiving dinner, a University of British...argest animals on earth feasts on the smallest of ...ls are known for their extraordinarily long dive t...ater for an hour at a time by lowering their heart...muscles. , "Weighing up to 40 tons, humpback whal...
Other Biology News:French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 3Master gene plays key role in blood sugar levels 2UBC researcher reveals humpback whales' dining habits -- and costs 2
Microarray Spotting Solution for Silane Coated Slides from Sigma-Aldrich
...the base hold 10 l of water to maintain chamber hu... coverslip. The watertight seal eliminates the ris...used with either constant temperature waterbaths o... a new product number, created to easily match Cor...
Eppendorf MicroDissector from Eppendorf North America
Techne hybridization oven Hybrigene from Sigma-Aldrich
Biology Products: